Expiring federal contract · order under a contract vehicle
75N98026F00001 — Roche Diagnostics Corporation
Department of Health and Human Services · National Institutes of Health
- Contract / PIID
- 75N98026F00001
- Incumbent
- Roche Diagnostics Corporation
- Incumbent UEI
- JDMDFEZBYH36
- Current end date
- August 31, 2027
- Potential total value
- $126,690
- Obligated
- $126,690
- NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- PSC
- R499 — LABORATORY EQUIPMENT AND SUPPLIES
- Set-aside
- Not stated
- Start date
- September 1, 2026
- Place of performance
- IN
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.
What the contract covers
TASK ORDER TO FUND OPTION YEAR TWO
Likely rebid window (estimate)
- Sources Sought / RFI: about Aug 2026 – Feb 2027 (6–12 months before the end date)
- RFP: about Apr 2027 – Jun 2027 (2–4 months before the end date)
Now inside the estimated Sources Sought / RFI window.
This is an order under contract vehicle 75N90024D00008. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325414)
- 75A50125C00002 — Sanofi Vaccines US INC. · ends January 31, 2027 · $53M
- 75A50124F61004 — Advanced Technology International · ends April 11, 2027 · $51M
- 75A50126F61013 — Seqirus INC · ends May 8, 2027 · $450K
- 75N93023P00594 — Dna Twopointo INC. · ends May 13, 2027 · $300K
- 75N98026P00545 — Somalogic Operating CO., INC · ends May 14, 2027 · $522K
- 75A50124F61008 — Seqirus INC · ends May 21, 2027 · $23M
- 75A50124F61009 — Seqirus INC · ends May 21, 2027 · $396K
- 75N98026P00626 — Olink Proteomics INC · ends May 28, 2027 · $207K
- 75N98026P00928 — Pacific Biosciences Of California, INC · ends July 7, 2027 · $347K
- 75N98026P01001 — Life Technologies Corporation · ends August 6, 2027 · $110K